Skip to content
In deliveryUnited KingdomGoods£4,090,814

Transitional Drugs 4

Published
Published 9 June 2025
Deadline
Closed 6 August 2025

Overview

This contract is for the provision of Transitional Drugs 4 - namely Ticagrelor and Eltrombopag

Key details

Country
United Kingdom
Status
In delivery
Category
Goods
Estimated value
£4,090,814
Procedure
Open
SME suitable
Yes
Published
9 June 2025
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
£137,717
Award date
4 September 2025
Contract period
30 September 2025 → 31 January 2027
Winners
  • Amarox Pharma
  • Novartis
  • Novumgen Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    25 October 2025

    View notice ↗
  2. Contract

    5 September 2025

    View notice ↗
  3. Contract Notice

    7 July 2025

    View notice ↗
  4. Prior Information Notice

    9 June 2025

    View notice ↗

Contracting authority

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

    Buyer

    Cardiff, United Kingdom

    GB-NHS: RQF

    Authority website ↗
  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

    Buyer

    Cardiff, United Kingdom

    GB-PPON: PXWV-6492-CGMN

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Transitional Drugs 4 — won by Amarox Pharma +2 — Skim